Výsledky vyhledávání - David Eichenbaum

  • Zobrazuji výsledky 1 - 14 z 14
Upřesnit hledání
  1. 1
    Real-world efficacy and safety of 8 mg aflibercept in neovascular AMD: a case series

    Real-world efficacy and safety of 8 mg aflibercept in neovascular AMD: a case series Autor Deepak Sambhara, Priya Vakharia, David Eichenbaum

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Autor Arshad M. Khanani, David Eichenbaum, Patricio G. Schlottmann, Lisa Tuomi, David Sarraf

    Vydáno 2018
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review

    Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review Autor Saira Khanna, Rahul Komati, David Eichenbaum, Ishani Hariprasad, Thomas A. Ciulla, Seenu M. Hariprasad

    Vydáno 2019
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy

    Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy Autor Charles C. Wykoff, David Eichenbaum, Daniel B. Roth, Lauren Hill, Anne E. Fung, Zdenka Hašková

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review

    Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review Autor Ian M. Leitch, Michael Gerometta, David Eichenbaum, Robert P. Finger, Nathan Steinle, Megan E. Baldwin

    Vydáno 2024
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Angiopoietins as Potential Targets in Management of Retinal Disease

    Angiopoietins as Potential Targets in Management of Retinal Disease Autor Arshad M. Khanani, Matthew W. Russell, Aamir Aziz, Carl J. Danzig, Christina Y. Weng, David Eichenbaum, Rishi P. Singh

    Vydáno 2021
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration

    Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration Autor Ana Bety Enríquez, Caroline R. Baumal, Ashley M. Crane, André J. Witkin, David R. Lally, Michelle C. Liang, José Ramón Enríquez, David Eichenbaum

    Vydáno 2021
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

    Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial Autor Sunil Patel, David R. Lally, Jason Hsu, Charles C. Wykoff, David Eichenbaum, Jeffrey S. Heier, Glenn J. Jaffe, Keith Westby, Dhaval Desai, Liansheng Zhu, Arshad M. Khanani

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study

    Biosimilar Ranibizumab (Ranieyes) Safety and Efficacy in the Real World: BRESER Study Autor Ashish Sharma, Frank G. Holz, Nilesh Kumar, David Sarraf, Seemantini Ayachit, Chitaranjan Mishra, Adnan Tufail, Debdulal Chakraborty, Neha Sharma, David Eichenbaum, Alay Banker, Nikulaa Parachuri, Ashish Kumar, Anat Loewenstein, Francesco Bandello, Taku Wakabayashi, Se Joon Woo, Baruch D. Kuppermann

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised,... Autor Charles C. Wykoff, Francis Abreu, Anthony P. Adamis, Karen Basu, David Eichenbaum, Zdenka Hašková, Hugh Lin, Anat Loewenstein, Shaun Mohan, Ian Pearce, Taiji Sakamoto, Patricio G. Schlottmann, David G. Silverman, Jennifer K. Sun, John A. Wells, Jeffrey R. Willis, Ramin Tadayoni, Thomas M. Aaberg, Ashkan M. Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel G. Adams, Alfredo Adán, Sean D. Adrean, Hansjürgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel, Jaroslava Dusova, David Eichenbaum, Bora Eldem

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration

    Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration Autor William R. Freeman, Francesco Bandello, Eric H. Souied, Robyn H. Guymer, Sunir J. Garg, Fred K. Chen, Ryan Rich, Frank G. Holz, Sunil Patel, Kimmie Kim, Francisco J. López, Fred K. Chen, Robyn H. Guymer, Jean‐François Korobelnik, Eric H. Souied, Frank G. Holz, Focke Ziemssen, Francesco Bandello, Emilio C. Campos, Chiara GrignoloEandi, Edoardo Midena, Enrico Peiretti, Giovanni Staurenghi, Francesco Viola, Clare Bailey, Simona Degli Esposti, Timothy L. Jackson, Geeta Menon, Sergio Pagliarini, Fahd Quhill, Andrew N. Antoszyk, Logan Brooks, David Callanan, Karl G. Csaky, Albert O. Edwards, David Eichenbaum, William R. Freeman, Sunir J. Garg, Avtar Thomas Ghuman, Víctor H. González, Sunil Gupta, Richard Hamilton, Rahul N. Khurana, Derek Kunimoto, Baruch D. Kuppermann, Andreas Lauer, Seong-Young Lee, Raj K. Maturi, Sunil Patel, Rahul Reddy, Ryan Rich, Mark Rivellese, Steven Rose, Zachary Segal, Robert Wong

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

    Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Autor Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J. Danzig, David Eichenbaum, Jason Hsu, Charles C. Wykoff, Jeffrey S. Heier, David R. Lally, Jordi Monés, Jared S. Nielsen, Veeral Sheth, Peter K. Kaiser, Julie Clark, Liansheng Zhu, Hersh Patel, Justin Tang, Dhaval Desai, Glenn J. Jaffe, Arturo Alezzandrini, A Francone, Joaquín Bafalluy, Silvina Bainttein, José D. Luna, Mario Saravia, Matko Vidosevich, Carlos Zeolite, Federico Furno Sola, Andrew Chang, Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella, Michele Figus

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked... Autor Jeffrey S. Heier, Arshad M. Khanani, Carlos Quezada-Ruiz, Karen Basu, Philip J. Ferrone, Christopher Brittain, Marta S. Figueroa, Hugh Lin, Frank G. Holz, Vaibhavi Patel, Timothy Y. Y. Lai, David G. Silverman, Carl D. Regillo, Balakumar Swaminathan, Francesco Viola, Chui Ming Gemmy Cheung, Tien Yin Wong, Ashkan M. Abbey, Elmira Abdulaeva, Prema Abraham, Alfredo Adán, Hansjürgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement K. Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Chui Ming Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell, Nicholas Fung, Federico Furno Sola, Richard Gale

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    TENAYA and LUCERNE

    TENAYA and LUCERNE Autor Arshad M. Khanani, Aachal Kotecha, Andrew Chang, Shih‐Jen Chen, Youxin Chen, Robyn H. Guymer, Jeffrey S. Heier, Frank G. Holz, Tomohiro Iida, Jane A. Ives, Jennifer I. Lim, Hugh Lin, Stephan Michels, Carlos Quezada-Ruiz, Ursula Schmidt‐Erfurth, David G. Silverman, Rishi P. Singh, Balakumar Swaminathan, Jeffrey R. Willis, Ramin Tadayoni, Ashkan M. Abbey, Elmira Abdulaeva, Prema Abraham, Alfredo Adán, Hansjürgen Agostini, Arturo Alezzandrini, Virgil Alfaro, Arghavan Almony, Lebriz Altay, Payam Amini, Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Chui Ming Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: